Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Abbott (NYSE: ABT), a global healthcare leader, today announced results from the FreeDM2 randomized controlled trial (RCT) showing that people using FreeStyle Libre continuous glucose monitoring (CGM) ...
FierceBiotech

Abbott's FreeStyle Libre CGM reduces Type 2 diabetes hospitalizations by 67%: study

Abbott’s FreeStyle Libre glucose sensor has already been proven to help people with both Type 1 and Type 2 diabetes better manage their blood sugar levels, and a new study demonstrates just how ...
Healio

Abbott warns FreeStyle Libre users about rare cases of battery swelling, overheating

Please provide your email address to receive an email when new articles are posted on . A voluntary medical device correction warned users of three Abbott FreeStyle Libre readers about the risk of ...
abc7NY

4.2M FreeStyle Libre glucose monitors recalled by FDA for risk of overheating, fire

At least seven fires and one injury that were related to some FreeStyle Libre glucose monitor products have led the US Food and Drug Administration to issue a Class I recall, the agency's strongest, ...

Abbott: Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. fingersticks 1 ...